Vystar Corp (VYST) stock
Close on Oct 19, 2026Market cap $1.80MP/E –Yield –
Vystar Corp saw revenue fall 47.4% to $44.46K over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $1.80M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.80M
- P/E ratio
- –
- Price to sales
- 40.59
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $44.46K
- Net income
- -$1.16M
- EPS, diluted
- -$0.04
- Book value per share
- -$0.29
- Diluted shares
- 25M
Trading
- Previous close
- $0.07
- Open
- $0.07
- Day's range
- $0.07 – $0.07
- Volume
- 848
- Average volume (20 days)
- 28,008
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | VYST | S&P 500 | Difference | VYST per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -24.8% | +0.6% | −25.4 pts | ||
| 3 months | -64.2% | +3.4% | −67.6 pts | ||
| Year to date | +62.9% | +13.3% | +49.6 pts | ||
| 1 year | -39.4% | +16.6% | −56.0 pts | ||
| 3 years | +7230.0% | +86.4% | +7143.6 pts | +318.5% | +23.1% |
| 5 years | -94.4% | +81.9% | −176.2 pts | -43.7% | +12.7% |
| 10 years | -99.6% | +318.9% | −418.4 pts | -42.0% | +15.4% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Vystar filed with the SEC as exhibits to Form 8-K or 6-K
About Vystar
Fabricated Rubber Products, NEC
Vystar Corporation manufactures and develops environmentally friendly products across three primary brands: Vytex, RxAir, and Fluid Energy Conversion (FEC). Its Vytex line produces ultra-low protein natural rubber latex used in consumer bedding such as mattresses, toppers, and pillows, as well as industrial and medical applications like gloves and adhesives. The RxAir segment develops and distributes ultraviolet air purifiers and hospital-grade filtration units certified as medical devices to eliminate airborne microorganisms. FEC develops fluidic technologies for energy and fluid management applications. The company targets consumer, commercial, and healthcare markets.
Company profile, executives and historyVystar stock: common questions
What is Vystar's stock price?
VYST closed at $0.07 on Oct 19, 2026, down 0.61% on the day.
What is Vystar's market cap?
Vystar was worth $1.80M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is VYST's P/E ratio?
Vystar lost money over the twelve months to Jun 30, 2026 (diluted EPS -$0.04), so it has no meaningful P/E ratio.
How much revenue does Vystar make?
Vystar reported revenue of $44.46K for the twelve months to Jun 30, 2026, down 47.4% from a year earlier.
Does Vystar pay a dividend?
No. Vystar has not paid a cash dividend over the last twelve months.
How has VYST stock performed over the past year?
Including dividends, VYST returned -39.4% over the past year, against +16.6% for the S&P 500.
Who are Vystar's competitors?
Companies most similar to Vystar by business, industry and size include AOXY, BGMS, USDW, CUPR, BDPT.
See a number that looks wrong?